# Learning from nature: HIV elite controllers as blueprints for a functional cure

**Authors:** V. Kalidasan, Kumitaa Theva Das

PMC · DOI: 10.1186/s12985-025-03042-9 · Virology Journal · 2025-12-24

## TL;DR

This paper explores how studying HIV elite controllers, who naturally suppress the virus, can guide the development of a functional cure for HIV.

## Contribution

The paper provides a comprehensive review of biological mechanisms in elite controllers that could inform scalable strategies for durable HIV remission.

## Key findings

- Elite controllers maintain viral suppression without ART, suggesting durable remission is biologically possible.
- Genetic, immune, and viral factors in elite controllers offer insights for developing functional cure strategies.
- Translational approaches like gene editing and immune modulation are informed by elite controller biology.

## Abstract

Antiretroviral therapy (ART) has transformed HIV infection into a manageable chronic condition but remains non-curative and requires lifelong adherence. Rare cases of long-term remission following stem cell transplantation (SCT) have demonstrated the possibility of viral eradication, yet this approach is not scalable or safe for global implementation. A unique subset of people living with HIV, known as elite controllers (ECs), can naturally suppress replication-competent HIV without ART, often for decades, while maintaining stable CD4 + T cell counts and showing no signs of disease progression. Their ability to sustain treatment-free viral suppression provides compelling evidence that durable remission is biologically achievable, offering a model for cure research. This review synthesizes current evidence on the biology of ECs, encompassing viral, intrinsic antiviral, genetic, and immune mechanisms that underlie natural control. It also examines demographic and clinical characteristics, landmark case reports, and the broader public health implications of elite control. Finally, insights from EC biology are discussed in relation to translational strategies such as gene editing, immune modulation, therapeutic vaccination, and reservoir-targeting approaches designed to mimic or reinforce natural control mechanisms. Understanding the determinants of viral suppression in ECs provides a biological blueprint for the development of a functional cure. As the field advances toward scalable, safe, and durable remission strategies, lessons from ECs remain central to achieving long-term viral control and ultimately ending the HIV epidemic.

## Linked entities

- **Diseases:** HIV infection (MONDO:0005109)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** HIV infection (MESH:D015658)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849495/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849495/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849495/full.md

---
Source: https://tomesphere.com/paper/PMC12849495